What is Opdivo (what it’s for)?
Opdivo (nivolumab) is an immunotherapy medicine that helps the immune system recognize and attack certain cancers. It is used for multiple cancer types, including cancers where tumors can evade the immune system by using pathways like PD-1.
Which cancers is Opdivo used for?
Opdivo is prescribed for several different cancers (for example, melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancers, and some cancers treated in combination regimens). The exact approved use depends on the specific cancer type, stage, and whether it’s being used alone or with other treatments.
How does Opdivo work in the body?
Opdivo is a PD-1 checkpoint inhibitor. By blocking PD-1, it can help T cells stay active against cancer cells, which is why it can work across multiple tumor types rather than just one.
Is Opdivo a chemotherapy or an immune drug?
Opdivo is not chemotherapy. It is an immune checkpoint inhibitor (immunotherapy). It may be used as a single agent or in combination with other cancer treatments, depending on the indication.
What do people usually mean by “Opdivo for”?
Most searches phrased as “Opdivo for …” are really asking one of two things:
1) what cancer type Opdivo treats (for example, “Opdivo for lung cancer” or “Opdivo for melanoma”), or
2) what treatment goal it supports (for example, shrinking tumors, helping prevent recurrence in certain settings, or treating advanced/unresectable disease).
If you tell me the cancer type (and whether you mean Opdivo alone or with another drug), I can narrow down what it’s prescribed for in that situation.